{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3CLpro", "ADMET", "MERS-CoV", "Molecular docking", "Molecular dynamics simulation", "Phytoconstituents"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38379969", "DateRevised": {"Year": "2024", "Month": "02", "Day": "22"}, "Article": {"Language": ["eng"], "ELocationID": ["e25837", "10.1016/j.heliyon.2024.e25837"], "ArticleDate": [{"Year": "2024", "Month": "02", "Day": "09"}], "Journal": {"ISSN": "2405-8440", "JournalIssue": {"Volume": "10", "Issue": "4", "PubDate": {"Year": "2024", "Month": "Feb", "Day": "29"}}, "Title": "Heliyon", "ISOAbbreviation": "Heliyon"}, "ArticleTitle": "An <i>in silico</i> approach to develop potential therapies against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).", "Pagination": {"StartPage": "e25837", "MedlinePgn": "e25837"}, "Abstract": {"AbstractText": ["A deadly respiratory disease Middle East Respiratory Syndrome (MERS) is caused by a perilous virus known as MERS-CoV, which has a severe impact on human health. Currently, there is no approved vaccine, prophylaxis, or antiviral therapeutics for preventing MERS-CoV infection. Due to its inexorable and integral role in the maturation and replication of the MERS-CoV virus, the 3C-like protease is unavoidly a viable therapeutic target. In this study, 2369 phytoconstituents were enlisted from Japanese medicinal plants, and these compounds were screened against 3C-like protease to identify feasible inhibitors. The best three compounds were identified as Kihadanin B, Robustaflavone, and 3-beta-O- (<i>trans</i>-p-Coumaroyl) maslinic acid, with binding energies of -9.8, -9.4, and -9.2\u00a0kcal/mol, respectively. The top three potential candidates interacted with several active site residues in the targeted protein, including Cys145, Met168, Glu169, Ala171, and Gln192. The best three compounds were assessed by <i>in silico</i> technique to determine their drug-likeness properties, and they exhibited the least harmful features and the greatest drug-like qualities. Various descriptors, such as solvent-accessible surface area, root-mean-square fluctuation, root-mean-square deviation, hydrogen bond, and radius of gyration, validated the stability and firmness of the protein-ligand complexes throughout the 100ns molecular dynamics simulation. Moreover, the top three compounds exhibited better binding energy along with better stability and firmness than the inhibitor (Nafamostat), which was further confirmed by the binding free energy calculation. Therefore, this computational investigation could aid in the development of efficient therapeutics for life-threatening MERS-CoV infections."], "CopyrightInformation": "\u00a9 2024 The Authors."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbiology Laboratory, Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, 6205, Bangladesh."}], "LastName": "Biswas", "ForeName": "Suvro", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, 6205, Bangladesh."}], "LastName": "Mita", "ForeName": "Mohasana Akter", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, 6205, Bangladesh."}], "LastName": "Afrose", "ForeName": "Shamima", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, 6205, Bangladesh."}], "LastName": "Hasan", "ForeName": "Md Robiul", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, 6205, Bangladesh."}], "LastName": "Shimu", "ForeName": "Mst Sharmin Sultana", "Initials": "MSS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbiology Laboratory, Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, 6205, Bangladesh."}], "LastName": "Zaman", "ForeName": "Shahriar", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbiology Laboratory, Department of Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, 6205, Bangladesh."}], "LastName": "Saleh", "ForeName": "Md Abu", "Initials": "MA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Heliyon", "NlmUniqueID": "101672560", "ISSNLinking": "2405-8440"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Alshukairi A.N., Zheng J., Zhao J., Nehdi A., Baharoon S.A., Layqah L., Bokhari A., Al Johani S.M., Samman N., Boudjelal M., Ten Eyck P., Al-Mozaini M.A., Zhao J., Perlman S., Alagaili A.N. High prevalence of MERS-CoV infection in camel workers in Saudi Arabia. mBio. 2018;9:1\u201310. doi: 10.1128/MBIO.01985-18.", "ArticleIdList": ["10.1128/MBIO.01985-18", "PMC6212820", "30377284"]}, {"Citation": "Zhang Z., Shen L., Gu X. Evolutionary dynamics of MERS-CoV: potential recombination, positive selection and transmission. Sci. Rep. 2016;6 doi: 10.1038/srep25049.", "ArticleIdList": ["10.1038/srep25049", "PMC4855236", "27142087"]}, {"Citation": "Haagmans B.L., Al Dhahiry S.H.S., Reusken C.B.E.M., Raj V.S., Galiano M., Myers R., Godeke G.J., Jonges M., Farag E., Diab A., Ghobashy H., Alhajri F., Al-Thani M., Al-Marri S.A., Al Romaihi H.E., Al Khal A., Bermingham A., Osterhaus A.D.M.E., AlHajri M.M., Koopmans M.P.G. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect. Dis. 2014;14:140\u2013145. doi: 10.1016/S1473-3099(13)70690-X.", "ArticleIdList": ["10.1016/S1473-3099(13)70690-X", "PMC7106553", "24355866"]}, {"Citation": "Li F., Du L. MERS Coronavirus: an emerging zoonotic virus. Viruses. 2019;11:1\u20136. doi: 10.3390/v11070663.", "ArticleIdList": ["10.3390/v11070663", "PMC6669680", "31331035"]}, {"Citation": "Masood N., Malik S.S., Raja M.N., Mubarik S., Yu C. Unraveling the epidemiology, geographical distribution, and genomic evolution of potentially lethal coronaviruses (SARS, MERS, and SARS CoV-2) Front. Cell. Infect. Microbiol. 2020;10:1\u20138. doi: 10.3389/fcimb.2020.00499.", "ArticleIdList": ["10.3389/fcimb.2020.00499", "PMC7481402", "32974224"]}, {"Citation": "Raj V.S., Osterhaus A.D.M.E., Fouchier R.A.M., Haagmans B.L. MERS: emergence of a novel human coronavirus. Curr. Opin. Virol. 2014;5:58\u201362. doi: 10.1016/j.coviro.2014.01.010.", "ArticleIdList": ["10.1016/j.coviro.2014.01.010", "PMC4028407", "24584035"]}, {"Citation": "Lu R., Wang Y., Wang W., Nie K., Zhao Y., Su J., Deng Y., Zhou W., Li Y., Wang H., Wang W., Ke C., Ma X., Wu G., Tan W. Complete genome sequence of Middle East respiratory syndrome coronavirus (MERS-CoV) from the first imported MERS-CoV case in China. Genome Announc. 2015;3:2014\u20132015. doi: 10.1128/genomeA.00818-15.", "ArticleIdList": ["10.1128/genomeA.00818-15", "PMC4536671", "26272560"]}, {"Citation": "Chafekar A., Fielding B.C. MERS-CoV: understanding the latest human coronavirus threat. Viruses. 2018;10 doi: 10.3390/v10020093.", "ArticleIdList": ["10.3390/v10020093", "PMC5850400", "29495250"]}, {"Citation": "Ba Abduallah M.M., Hemida M.G. Comparative analysis of the genome structure and organization of the Middle East respiratory syndrome coronavirus (MERS-CoV) 2012 to 2019 revealing evidence for virus strain barcoding, zoonotic transmission, and selection pressure. Rev. Med. Virol. 2021;31:1\u201312. doi: 10.1002/rmv.2150.", "ArticleIdList": ["10.1002/rmv.2150", "PMC7461035", "32803835"]}, {"Citation": "Qian Z., Dominguez S.R., Holmes K.V. Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation. PLoS One. 2013;8:1\u201312. doi: 10.1371/journal.pone.0076469.", "ArticleIdList": ["10.1371/journal.pone.0076469", "PMC3789674", "24098509"]}, {"Citation": "Millet J.K., Whittaker G.R. Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. Virology. 2018;517:3\u20138. doi: 10.1016/j.virol.2017.12.015.", "ArticleIdList": ["10.1016/j.virol.2017.12.015", "PMC7112017", "29275820"]}, {"Citation": "Liang R., Wang L., Zhang N., Deng X., Su M., Su Y., Hu L., He C., Ying T., Jiang S., Yu F. Development of small-molecule MERS-CoV inhibitors. Viruses. 2018;10 doi: 10.3390/v10120721.", "ArticleIdList": ["10.3390/v10120721", "PMC6316138", "30562987"]}, {"Citation": "Raj V.S., Mou H., Smits S.L., Dekkers D.H.W., M\u00fcller M.A., Dijkman R., Muth D., Demmers J.A.A., Zaki A., Fouchier R.A.M., Thiel V., Drosten C., Rottier P.J.M., Osterhaus A.D.M.E., Bosch B.J., Haagmans B.L. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495:251\u2013254. doi: 10.1038/nature12005.", "ArticleIdList": ["10.1038/nature12005", "PMC7095326", "23486063"]}, {"Citation": "Pillaiyar T. Middle East respiratory syndrome-coronavirus (MERS-CoV): an updated overview and pharmacotherapeutics. Med. Chem. 2015 doi: 10.4172/2161-0444.1000287.", "ArticleIdList": ["10.4172/2161-0444.1000287"]}, {"Citation": "Xia S., Liu Q., Wang Q., Sun Z., Su S., Du L., Ying T., Lu L., Jiang S. Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein. Virus Res. 2014;194:200\u2013210. doi: 10.1016/j.virusres.2014.10.007.", "ArticleIdList": ["10.1016/j.virusres.2014.10.007", "PMC7114414", "25451066"]}, {"Citation": "Lu L., Liu Q., Zhu Y., Chan K.H., Qin L., Li Y., Wang Q., Chan J.F.W., Du L., Yu F., Ma C., Ye S., Yuen K.Y., Zhang R., Jiang S. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat. Commun. 2014;5 doi: 10.1038/ncomms4067.", "ArticleIdList": ["10.1038/ncomms4067", "PMC7091805", "24473083"]}, {"Citation": "Alamri M.A., Tahir ul Qamar M., Afzal O., Alabbas A.B., Riadi Y., Alqahtani S.M. Discovery of anti-MERS-CoV small covalent inhibitors through pharmacophore modeling, covalent docking and molecular dynamics simulation. J. Mol. Liq. 2021;330 doi: 10.1016/j.molliq.2021.115699.", "ArticleIdList": ["10.1016/j.molliq.2021.115699", "PMC8040153", "33867606"]}, {"Citation": "Shirato K., Kawase M., Matsuyama S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J. Virol. 2013;87:12552\u201312561. doi: 10.1128/jvi.01890-13.", "ArticleIdList": ["10.1128/jvi.01890-13", "PMC3838146", "24027332"]}, {"Citation": "Kumar V., Shin J.S., Shie J.J., Ku K.B., Kim C., Go Y.Y., Huang K.F., Kim M., Liang P.H. Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CLpro inhibitors. Antivir. Res. 2017;141:101\u2013106. doi: 10.1016/j.antiviral.2017.02.007.", "ArticleIdList": ["10.1016/j.antiviral.2017.02.007", "PMC7113684", "28216367"]}, {"Citation": "Needle D., Lountos G.T., Waugh D.S. Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity. Acta Crystallogr. Sect. D Biol. Crystallogr. 2015;71:1102\u20131111. doi: 10.1107/S1399004715003521.", "ArticleIdList": ["10.1107/S1399004715003521", "PMC4427198", "25945576"]}, {"Citation": "Jo S., Kim H., Kim S., Shin D.H., Kim M.S. Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors. Chem. Biol. Drug Des. 2019;94:2023\u20132030. doi: 10.1111/cbdd.13604.", "ArticleIdList": ["10.1111/cbdd.13604", "PMC7162010", "31436895"]}, {"Citation": "Knoops K., Kikkert M., Van Den Worm S.H.E., Zevenhoven-Dobbe J.C., Van Der Meer Y., Koster A.J., Mommaas A.M., Snijder E.J. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol. 2008;6:1957. doi: 10.1371/journal.pbio.0060226. \u20131974.", "ArticleIdList": ["10.1371/journal.pbio.0060226", "PMC2535663", "18798692"]}, {"Citation": "Wang F., Chen C., Tan W., Yang K., Yang H. Structure of main protease from human coronavirus NL63: insights for wide spectrum anti-coronavirus drug design. Sci. Rep. 2016;6:1\u201312. doi: 10.1038/srep22677.", "ArticleIdList": ["10.1038/srep22677", "PMC4780191", "26948040"]}, {"Citation": "Hilgenfeld R. From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J. 2014;281:4085\u20134096. doi: 10.1111/febs.12936.", "ArticleIdList": ["10.1111/febs.12936", "PMC7163996", "25039866"]}, {"Citation": "He J., Hu L., Huang X., Wang C., Zhang Z., Wang Y. Elsevier Connect , the company \u2019 s public news and information; 2020. Since January 2020 Elsevier Has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID- 19 . The COVID-19 Resource Centre Is Hosted on."}, {"Citation": "Tomar S., Johnston M.L., John S.E.S., Osswald H.L., Nyalapatla P.R., Paul L.N., Ghosh A.K., Denison M.R., Mesecar A.D. Ligand-induced dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 protease (3CLpro): implications for nsp5 regulation and the development of antivirals. J. Biol. Chem. 2015;290:19403\u201319422. doi: 10.1074/jbc.M115.651463.", "ArticleIdList": ["10.1074/jbc.M115.651463", "PMC4528106", "26055715"]}, {"Citation": "Bahadur Gurung A., Ajmal Ali M., Lee J., Abul Farah M., Mashay Al-Anazi K. Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme. J. King Saud Univ. Sci. 2020;32:2845\u20132853. doi: 10.1016/j.jksus.2020.07.007.", "ArticleIdList": ["10.1016/j.jksus.2020.07.007", "PMC7366079", "32837113"]}, {"Citation": "Falzarano D., De Wit E., Martellaro C., Callison J., Munster V.J., Feldmann H. Inhibition of novel \u03b2 coronavirus replication by a combination of interferon-\u03b12b and ribavirin. Sci. Rep. 2013;3:1\u20136. doi: 10.1038/srep01686.", "ArticleIdList": ["10.1038/srep01686", "PMC3629412", "23594967"]}, {"Citation": "Cong Y., Hart B.J., Gross R., Zhou H., Frieman M., Bollinger L., Wada J., Hensley L.E., Jahrling P.B., Dyall J., Holbrook M.R. MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells. PLoS One. 2018;13:1\u201317. doi: 10.1371/journal.pone.0194868.", "ArticleIdList": ["10.1371/journal.pone.0194868", "PMC5864050", "29566060"]}, {"Citation": "Li Y., Wan Y., Liu P., Zhao J., Lu G., Qi J., Wang Q., Lu X., Wu Y., Liu W., Zhang B., Yuen K.Y., Perlman S., Gao G.F., Yan J. A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein. Cell Res. 2015;25:1237\u20131249. doi: 10.1038/cr.2015.113.", "ArticleIdList": ["10.1038/cr.2015.113", "PMC4650419", "26391698"]}, {"Citation": "Momattin H., Al-Ali A.Y., Al-Tawfiq J.A. A systematic review of therapeutic agents for the treatment of the Middle East respiratory syndrome coronavirus (MERS-CoV) Trav. Med. Infect. Dis. 2019;30:9\u201318. doi: 10.1016/j.tmaid.2019.06.012.", "ArticleIdList": ["10.1016/j.tmaid.2019.06.012", "PMC7110863", "31252170"]}, {"Citation": "Zhou Y., Jiang S., Du L. Prospects for a MERS-CoV spike vaccine. Expert Rev. Vaccines. 2018;17:677\u2013686. doi: 10.1080/14760584.2018.1506702.", "ArticleIdList": ["10.1080/14760584.2018.1506702", "PMC6355461", "30058403"]}, {"Citation": "Du L., Yang Y., Zhou Y., Lu L., Li F., Jiang S. MERS-CoV spike protein: a key target for antivirals. Expert Opin. Ther. Targets. 2017;21:131\u2013143. doi: 10.1080/14728222.2017.1271415.", "ArticleIdList": ["10.1080/14728222.2017.1271415", "PMC5457961", "27936982"]}, {"Citation": "Weskamm L.M., Fathi A., Raadsen M.P., Mykytyn A.Z., Koch T., Spohn M., Friedrich M., Bartels E., Gundlach S., Hesterkamp T., Kr\u00e4hling V., Lassen S., Ly M.L., P\u00f6tsch J.H., Schmiedel S., Volz A., Zinser M.E., Haagmans B.L., Becker S., Sutter G., Dahlke C., Addo M.M. Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine. Cell Reports Med. 2022;3 doi: 10.1016/j.xcrm.2022.100685.", "ArticleIdList": ["10.1016/j.xcrm.2022.100685", "PMC9295383", "35858586"]}, {"Citation": "Bosaeed M., Balkhy H.H., Almaziad S., Aljami H.A., Alhatmi H., Alanazi H., Alahmadi M., Jawhary A., Alenazi M.W., Almasoud A., Alanazi R., Bittaye M., Aboagye J., Albaalharith N., Batawi S., Folegatti P., Ramos Lopez F., Ewer K., Almoaikel K., Aljeraisy M., Alothman A., Gilbert S.C., Khalaf Alharbi N. Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial. The Lancet Microbe. 2022;3:e11\u2013e20. doi: 10.1016/S2666-5247(21)00193-2.", "ArticleIdList": ["10.1016/S2666-5247(21)00193-2", "PMC8565931", "34751259"]}, {"Citation": "Zhang N., Shang J., Li C., Zhou K., Du L. An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies. Expert Rev. Vaccines. 2020;19:817\u2013829. doi: 10.1080/14760584.2020.1813574.", "ArticleIdList": ["10.1080/14760584.2020.1813574", "PMC7755455", "32842811"]}, {"Citation": "Jiaming L., Yanfeng Y., Yao D., Yawei H., Linlin B., Baoying H., Jinghua Y., Gao G.F., Chuan Q., Wenjie T. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Vaccine. 2017;35:10\u201318. doi: 10.1016/j.vaccine.2016.11.064.", "ArticleIdList": ["10.1016/j.vaccine.2016.11.064", "PMC7115548", "27899228"]}, {"Citation": "Li E., Chi H., Huang P., Yan F., Zhang Y., Liu C., Wang Z., Li G., Zhang S., Mo R., Jin H., Wang H., Feng N., Wang J., Bi Y., Wang T., Sun W., Gao Y., Zhao Y., Yang S., Xia X. A novel bacterium-like particle vaccine displaying the MERS-CoV receptor-binding domain induces specific mucosal and systemic immune responses in mice. Viruses. 2019;11 doi: 10.3390/v11090799.", "ArticleIdList": ["10.3390/v11090799", "PMC6784119", "31470645"]}, {"Citation": "Bodmer B.S., Fiedler A.H., Hanauer J.R.H., Pr\u00fcfer S., M\u00fchlebach M.D. Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model. Virology. 2018;521:99\u2013107. doi: 10.1016/j.virol.2018.05.028.", "ArticleIdList": ["10.1016/j.virol.2018.05.028", "PMC7118890", "29902727"]}, {"Citation": "Rose P.W., Prli\u0107 A., Altunkaya A., Bi C., Bradley A.R., Christie C.H., Di Costanzo L., Duarte J.M., Dutta S., Feng Z., Green R.K., Goodsell D.S., Hudson B., Kalro T., Lowe R., Peisach E., Randle C., Rose A.S., Shao C., Tao Y.P., Valasatava Y., Voigt M., Westbrook J.D., Woo J., Yang H., Young J.Y., Zardecki C., Berman H.M., Burley S.K. The RCSB protein data bank: integrative view of protein, gene and 3D structural information. Nucleic Acids Res. 2017;45:D271\u2013D281. doi: 10.1093/nar/gkw1000.", "ArticleIdList": ["10.1093/nar/gkw1000", "PMC5210513", "27794042"]}, {"Citation": "Wl D. The PyMOL molecular graphics system. CCP4 Newsl. Protein Crystallogr. 2002;40:82\u201392."}, {"Citation": "D. Studio . Accelrys Softw. Inc.; 2015. Dassault Systemes BIOVIA, Discovery Studio Modelling Environment, Release 4.5."}, {"Citation": "Land H., Humble M.S. In: YASARA: A Tool to Obtain Structural Guidance in Biocatalytic Investigations BT - Protein Engineering: Methods and Protocols. Bornscheuer U.T., H\u00f6hne M., editors. Springer New York; New York, NY: 2018. pp. 43\u201367.", "ArticleIdList": ["10.1007/978-1-4939-7366-8_4", "29086303"]}, {"Citation": "Kim S., Chen J., Cheng T., Gindulyte A., He J., He S., Li Q., Shoemaker B., Thiessen P., U B., Zaslavsky L., Zhang J., Bolton E. PubChem substance and compound databases. Nucleic Acids Res. 2019;47(D1):D1202\u2013D1213. D11.", "ArticleIdList": ["PMC4702940", "26400175"]}, {"Citation": "Halgren T.A. Performance of MMFF94*, scope, parameterization. J. Comput. Chem. 1996;17:490\u2013519."}, {"Citation": "Lin S.C., Ho C.T., Chuo W.H., Li S., Wang T.T., Lin C.C. Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect. Dis. 2017;17:1\u201310. doi: 10.1186/s12879-017-2253-8.", "ArticleIdList": ["10.1186/s12879-017-2253-8", "PMC5307780", "28193191"]}, {"Citation": "Sauerhering L., Kupke A., Meier L., Dietzel E., Hoppe J., Gruber A.D., Gattenloehner S., Witte B., Fink L., Hofmann N., Zimmermann T., Goesmann A., Nist A., Stiewe T., Becker S., Herold S., Peteranderl C. Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus via interferon-\u03bb in vitro and in mice. Eur. Respir. J. 2020;56 doi: 10.1183/13993003.01826-2019.", "ArticleIdList": ["10.1183/13993003.01826-2019", "PMC7331652", "32616594"]}, {"Citation": "Al-Tawfiq J.A., Memish Z.A. Update on therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV) Expert Rev. Anti Infect. Ther. 2017;15:269\u2013275. doi: 10.1080/14787210.2017.1271712.", "ArticleIdList": ["10.1080/14787210.2017.1271712", "PMC7103731", "27937060"]}, {"Citation": "Yamamoto M., Matsuyama S., Li X., Takeda M., Kawaguchi Y., Inoue J.I., Matsuda Z. Identification of nafamostat as a potent inhibitor of middle east respiratory syndrome Coronavirus s protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay. Antimicrob. Agents Chemother. 2016;60:6532\u20136539. doi: 10.1128/AAC.01043-16.", "ArticleIdList": ["10.1128/AAC.01043-16", "PMC5075056", "27550352"]}, {"Citation": "De Beer T.A.P., Berka K., Thornton J.M., Laskowski R.A. PDBsum additions. Nucleic Acids Res. 2014;42 doi: 10.1093/nar/gkt940.", "ArticleIdList": ["10.1093/nar/gkt940", "PMC3965036", "24153109"]}, {"Citation": "Trott oleg, Olson Arthur J., Vina AutoDock. Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31:455\u2013461.", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": "Cheng F., Li W., Zhou Y., Shen J., Wu Z., Liu G., Lee P.W., Tang Y. AdmetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J. Chem. Inf. Model. 2012;52:3099\u20133105. doi: 10.1021/ci300367a.", "ArticleIdList": ["10.1021/ci300367a", "23092397"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017;7:1\u201313. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Pires D.E.V., Blundell T.L., Ascher D.B. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 2015;58:4066\u20134072. doi: 10.1021/acs.jmedchem.5b00104.", "ArticleIdList": ["10.1021/acs.jmedchem.5b00104", "PMC4434528", "25860834"]}, {"Citation": "Wang J., Wolf R.M., Caldwell J.W., Kollman P.A., Case D.A. Development and testing of a general Amber force field. J. Comput. Chem. 2004;25:1157\u20131174. doi: 10.1002/jcc.20035.", "ArticleIdList": ["10.1002/jcc.20035", "15116359"]}, {"Citation": "Harrach M.F., Drossel B. Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity. J. Chem. Phys. 2014;140", "ArticleIdList": ["24811640"]}, {"Citation": "Essmann U., Perera L., Berkowitz M.L., Darden T., Lee H., Pedersen L.G. A smooth particle mesh Ewald method. J. Chem. Phys. 1995;103:8577\u20138593. doi: 10.1063/1.470117.", "ArticleIdList": ["10.1063/1.470117"]}, {"Citation": "Krieger E., Nielsen J.E., Spronk C.A.E.M., Vriend G. Fast empirical pKa prediction by Ewald summation. J. Mol. Graph. Model. 2006;25:481\u2013486. doi: 10.1016/j.jmgm.2006.02.009.", "ArticleIdList": ["10.1016/j.jmgm.2006.02.009", "16644253"]}, {"Citation": "Harvey M.J., De Fabritiis G. An implementation of the smooth particle mesh Ewald method on GPU hardware. J. Chem. Theor. Comput. 2009;5:2371\u20132377. doi: 10.1021/ct900275y.", "ArticleIdList": ["10.1021/ct900275y", "26616618"]}, {"Citation": "Krieger E., Vriend G. New ways to boost molecular dynamics simulations. J. Comput. Chem. 2015;36:996\u20131007.", "ArticleIdList": ["PMC6680170", "25824339"]}, {"Citation": "Mahfuz A., Khan M.A., Biswas S., Afrose S., Mahmud S., Bahadur N.M., Ahmed F. In search of novel inhibitors of anti-cancer drug target fibroblast growth factor receptors: insights from virtual screening, molecular docking, and molecular dynamics. Arab. J. Chem. 2022;15"}, {"Citation": "Mahmud S., Hasan M.R., Biswas S., Paul G.K., Afrose S., Mita M.A., Sultana Shimu M.S., Promi M.M., Hani U., Rahamathulla M., Khan M.A., Zaman S., Uddin M.S., Rahmatullah M., Jahan R., Alqahtani A.M., Saleh M.A., Bin Emran T. Screening of potent phytochemical inhibitors against SARS-CoV-2 main protease: an integrative computational approach. Front. Bioinforma. 2021;1:1\u201315. doi: 10.3389/fbinf.2021.717141.", "ArticleIdList": ["10.3389/fbinf.2021.717141", "PMC9581031", "36303755"]}, {"Citation": "Mahmud S., Mita M.A., Biswas S., Paul G.K., Promi M.M., Afrose S., Hasan R., Shimu S.S., Zaman S., Uddin S., Tallei T.E., Bin Emran T., Saleh A. Molecular docking and dynamics study to explore phytochemical ligand molecules against the main protease of SARS-CoV-2 from extensive phytochemical datasets. Expet Rev. Clin. Pharmacol. 2021;14:1305\u20131315. doi: 10.1080/17512433.2021.1959318.", "ArticleIdList": ["10.1080/17512433.2021.1959318", "34301158"]}, {"Citation": "Mahmud S., Biswas S., Kumar Paul G., Mita M.A., Afrose S., Robiul Hasan M., Sharmin Sultana Shimu M., Uddin M.A.R., Salah Uddin M., Zaman S., Kaderi Kibria K.M., Arif Khan M., Bin Emran T., Abu Saleh M. Antiviral peptides against the main protease of SARS-CoV-2: a molecular docking and dynamics study. Arab. J. Chem. 2021;14 doi: 10.1016/j.arabjc.2021.103315.", "ArticleIdList": ["10.1016/j.arabjc.2021.103315", "PMC8277949", "34909064"]}, {"Citation": "Mahmud S., Biswas S., Paul G.K., Mita M.A., Promi M.M., Afrose S., Hasan M.R., Zaman S., Uddin M.S., Dhama K., Bin Emran T., Saleh M.A., Simal-Gandara J. Plant-based phytochemical screening by targeting main protease of sars-cov-2 to design effective potent inhibitors. Biology. 2021;10 doi: 10.3390/biology10070589.", "ArticleIdList": ["10.3390/biology10070589", "PMC8301192", "34206970"]}, {"Citation": "Mahmud S., Rafi M.O., Paul G.K., Promi M.M., Shimu M.S.S., Biswas S., Bin Emran T., Dhama K., Alyami S.A., Moni M.A. Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach. Sci. Rep. 2021;11", "ArticleIdList": ["PMC8322212", "34326355"]}, {"Citation": "Mahmud S., Paul G.K., Biswas S., Afrose S., Mita M.A., Hasan M.R., Shimu M.S.S., Hossain A., Promi M.M., Ema F.K., Chidambaram K., Chandrasekaran B., Alqahtani A.M., Bin Emran T., Saleh M.A. Prospective role of peptide-based antiviral therapy against the main protease of SARS-CoV-2. Front. Mol. Biosci. 2021;8 doi: 10.3389/fmolb.2021.628585.", "ArticleIdList": ["10.3389/fmolb.2021.628585", "PMC8142691", "34041263"]}, {"Citation": "Mahmud S., Paul G.K., Afroze M., Islam S., Gupt S.B.R., Razu M.H., Biswas S., Zaman S., Uddin M.S., Khan M., Cacciola N.A., Bin Emran T., Saleh M.A., Capasso R., Simal-Gandara J. Efficacy of phytochemicals derived from avicennia officinalis for the management of covid-19: a combined in silico and biochemical study. Molecules. 2021;26 doi: 10.3390/molecules26082210.", "ArticleIdList": ["10.3390/molecules26082210", "PMC8070553", "33921289"]}, {"Citation": "Biswas S., Mahmud S., Mita M.A., Afrose S. vol. 8. 2022. pp. 1\u201310. (Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides against the Spike Receptor Binding Domain of SARS-CoV-2).", "ArticleIdList": ["10.3389/fmolb.2021.791642", "PMC8851422", "35187069"]}, {"Citation": "Paul G.K., Mahmud S., Aldahish A.A., Afroze M., Biswas S., Gupta S.B.R., Razu M.H., Zaman S., Uddin M.S., Nahari M.H. Computational screening and biochemical analysis of Pistacia integerrima and Pandanus odorifer plants to find effective inhibitors against Receptor-Binding domain (RBD) of the spike protein of SARS-Cov-2. Arab. J. Chem. 2022;15", "ArticleIdList": ["PMC8632739", "34909068"]}, {"Citation": "Massova I., Kollman P.A. Combined molecular mechanical and continuum solvent approach (MM- PBSA/GBSA) to predict ligand binding. Perspect. Drug Discov. Des. 2000;18:113\u2013135. doi: 10.1023/A:1008763014207.", "ArticleIdList": ["10.1023/A:1008763014207"]}, {"Citation": "Rakib A., Nain Z., Sami S.A., Mahmud S., Islam A., Ahmed S., Siddiqui A.B.F., Babu S.M.O.F., Hossain P., Shahriar A., Nainu F., Bin Emran T., Simal-Gandara J. A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico investigation. Briefings Bioinf. 2021;22:1476\u20131498. doi: 10.1093/bib/bbab045.", "ArticleIdList": ["10.1093/bib/bbab045", "PMC7929402", "33623995"]}, {"Citation": "Galasiti Kankanamalage A.C., Kim Y., Damalanka V.C., Rathnayake A.D., Fehr A.R., Mehzabeen N., Battaile K.P., Lovell S., Lushington G.H., Perlman S., Chang K.O., Groutas W.C. Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element. Eur. J. Med. Chem. 2018;150:334\u2013346. doi: 10.1016/j.ejmech.2018.03.004.", "ArticleIdList": ["10.1016/j.ejmech.2018.03.004", "PMC5891363", "29544147"]}, {"Citation": "Tareq Hassan Khan M. Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approaches. Curr. Drug Metabol. 2010;11:285\u2013295. doi: 10.2174/138920010791514306.", "ArticleIdList": ["10.2174/138920010791514306", "20450477"]}, {"Citation": "Lagorce D., Douguet D., Miteva M.A., Villoutreix B.O. Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors. Sci. Rep. 2017;7", "ArticleIdList": ["PMC5387685", "28397808"]}, {"Citation": "Klopman G., Stefan L.R., Saiakhov R.D. ADME evaluation: 2. A computer model for the prediction of intestinal absorption in humans. Eur. J. Pharmaceut. Sci. 2002;17:253\u2013263. doi: 10.1016/S0928-0987(02)00219-1.", "ArticleIdList": ["10.1016/S0928-0987(02)00219-1", "12453615"]}, {"Citation": "Guan L., Yang H., Cai Y., Sun L., Di P., Li W., Liu G., Tang Y. ADMET-score-a comprehensive scoring function for evaluation of chemical drug-likeness. Medchemcomm. 2019;10:148\u2013157. doi: 10.1039/C8MD00472B.", "ArticleIdList": ["10.1039/C8MD00472B", "PMC6350845", "30774861"]}, {"Citation": "Han Y., Zhang J., Hu C. A systematic toxicity evaluation of cephalosporins via transcriptomics in zebrafish and in silico ADMET studies. Food Chem. Toxicol. 2018;116:264\u2013271. doi: 10.1016/j.fct.2018.04.046.", "ArticleIdList": ["10.1016/j.fct.2018.04.046", "29689360"]}, {"Citation": "Islam S., Mahmud L., Almalki W.H., Biswas S., Islam A. Biofilm Formation; 2022. Cell-Free Supernatants (CFSs) from the Culture of Bacillus Subtilis Inhibit Pseudomonas Sp; pp. 1\u201314.", "ArticleIdList": ["PMC9692604", "36363697"]}, {"Citation": "Ramanathan K., Antognini D., Combes A., Paden M., Zakhary B., Ogino M., Maclaren G., Brodie D. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect. Dis. 2014;14:50\u201356.", "ArticleIdList": ["PMC3895322", "24239323"]}, {"Citation": "Sharif-Yakan A., Kanj S.S. Emergence of MERS-CoV in the Middle East: origins, transmission, treatment, and perspectives. PLoS Pathog. 2014;10 doi: 10.1371/journal.ppat.1004457.", "ArticleIdList": ["10.1371/journal.ppat.1004457", "PMC4256428", "25474536"]}, {"Citation": "Forni D., Filippi G., Cagliani R., De Gioia L., Pozzoli U., Al-Daghri N., Clerici M., Sironi M. The heptad repeat region is a major selection target in MERS-CoV and related coronaviruses. Sci. Rep. 2015;5:1\u201310. doi: 10.1038/srep14480.", "ArticleIdList": ["10.1038/srep14480", "PMC4585914", "26404138"]}, {"Citation": "Mubarak A., Alturaiki W., Hemida M.G. Middle east respiratory syndrome coronavirus (mers-cov): infection, immunological response, and vaccine development. J. Immunol. Res. 2019;2019 doi: 10.1155/2019/6491738.", "ArticleIdList": ["10.1155/2019/6491738", "PMC6476043", "31089478"]}, {"Citation": "Shi J., Sivaraman J., Song J. Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease. J. Virol. 2008;82:4620\u20134629. doi: 10.1128/jvi.02680-07.", "ArticleIdList": ["10.1128/jvi.02680-07", "PMC2293028", "18305031"]}, {"Citation": "Chuck C.P., Chow H.F., Wan D.C.C., Wong K.B. Profiling of substrate specificities of 3C-like proteases from group 1, 2a, 2b, and 3 coronaviruses. PLoS One. 2011;6 doi: 10.1371/journal.pone.0027228.", "ArticleIdList": ["10.1371/journal.pone.0027228", "PMC3206940", "22073294"]}, {"Citation": "St John S.E., Tomar S., Stauffer S.R., Mesecar A.D. Targeting zoonotic viruses: structure-based inhibition of the 3C-like protease from bat coronavirus HKU4--The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS) Bioorg. Med. Chem. 2015;23:6036\u20136048. doi: 10.1016/j.bmc.2015.06.039.", "ArticleIdList": ["10.1016/j.bmc.2015.06.039", "PMC5433438", "26190463"]}, {"Citation": "Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., Hilgenfeld R. Coronavirus main proteinase (3CLpro) Structure: basis for design of anti-SARS drugs. Science. 2003;300:1763\u20131767. doi: 10.1126/science.1085658.", "ArticleIdList": ["10.1126/science.1085658", "12746549"]}, {"Citation": "Baba S., Ueno Y., Kikuchi T., Tanaka R., Fujimori K. A limonoid Kihadanin B from immature Citrus unshiu peels suppresses adipogenesis through repression of the Akt-FOXO1-PPAR\u03b3 Axis in adipocytes. J. Agric. Food Chem. 2016;64:9607\u20139615. doi: 10.1021/acs.jafc.6b04521.", "ArticleIdList": ["10.1021/acs.jafc.6b04521", "27977180"]}, {"Citation": "Mbaveng A.T., Noulala C.G.T., Samba A.R.M., Tankeo S.B., Fotso G.W., Happi E.N., Ngadjui B.T., Beng V.P., Kuete V., Efferth T. Cytotoxicity of botanicals and isolated phytochemicals from Araliopsis soyauxii Engl.(Rutaceae) towards a panel of human cancer cells. J. Ethnopharmacol. 2021;267", "ArticleIdList": ["33166626"]}, {"Citation": "Kawaguchi H., Kim M., Ishida M., Ahn Y.-J., Yamamoto T., Yamaoka R., Kozuka M., Goto K., Takahashi S. Several antifeedants from Phellodendron amurense against Reticulitermes speratus. Agric. Biol. Chem. 1989;53:2635\u20132640."}, {"Citation": "Guo X.-X., Zhao L.-N., Wang J., Liu S., Bi Q.-R., Wang Z., Tan N.-H. Chemical constituents from root barks of Dictamnus dasycarpus and their cytotoxic activities. Zhongguo Zhong Yao Za Zhi= Zhongguo Zhongyao Zazhi= China J. Chinese Mater. Medica. 2018;43:4869\u20134877.", "ArticleIdList": ["30717533"]}, {"Citation": "Jo A., Yoo H.J., Lee M. Robustaflavone isolated from nandina domestica using bioactivity-guided fractionation downregulates inflammatory mediators. Molecules. 2019;24:2\u201313. doi: 10.3390/molecules24091789.", "ArticleIdList": ["10.3390/molecules24091789", "PMC6540067", "31072069"]}, {"Citation": "Ambarwati N.S.S., Elya B., Malik A., Omar H., Hanafi M., Ahmad I. New robustaflavone from Garcinia latissima Miq. leave and its antibacterial activity. J. Adv. Pharm. Technol. Res. 2022;13:50.", "ArticleIdList": ["PMC8820349", "35223441"]}, {"Citation": "Zembower D.E., Lin Y.M., Flavin M.T., Chen Fa-Ching, Korba B.E. Robustaflavone, a potential non-nucleoside anti-hepatitis B agent. Antivir. Res. 1998;39:81\u201388. doi: 10.1016/S0166-3542(98)00033-3.", "ArticleIdList": ["10.1016/S0166-3542(98)00033-3", "9806485"]}, {"Citation": "Ma Y., Wang Y., Zhang H., Sun W., Li Z., Zhang F., Zhang H., Chen F., Zhang H., An J., He C. Antimicrobial mechanism of strictinin isomers extracted from the root of Rosa roxburghii Tratt (Ci Li Gen) J. Ethnopharmacol. 2020;250 doi: 10.1016/j.jep.2019.112498.", "ArticleIdList": ["10.1016/j.jep.2019.112498", "31877366"]}, {"Citation": "Rahman M.M., Hosen M.B., Howlader M.Z.H., Kabir Y. Lead molecule prediction and characterization for designing MERS-CoV 3C-like protease inhibitors: an in silico approach. Curr. Comput. Aided Drug Des. 2019;15:82\u201388.", "ArticleIdList": ["29956635"]}, {"Citation": "Radwan A.A., Alanazi F.K. In silico studies on novel inhibitors of MERS-CoV: structure-based pharmacophore modeling, database screening and molecular docking. Trop. J. Pharmaceut. Res. 2018;17:513\u2013517. doi: 10.4314/tjpr.v17i3.18.", "ArticleIdList": ["10.4314/tjpr.v17i3.18"]}, {"Citation": "Galasiti Kankanamalage A.C., Kim Y., Damalanka V.C., Rathnayake A.D., Fehr A.R., Mehzabeen N., Battaile K.P., Lovell S., Lushington G.H., Perlman S., Chang K.O., Groutas W.C. Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element. Eur. J. Med. Chem. 2018;150:334\u2013346. doi: 10.1016/j.ejmech.2018.03.004.", "ArticleIdList": ["10.1016/j.ejmech.2018.03.004", "PMC5891363", "29544147"]}, {"Citation": "Ghosh C., Saha M., Kulavi S., Chatterjee S. In-silico screening of some important bioactive compounds as potential inhibitors of 3CLpro protein of SARS-CoV-2 and MERS-CoV virus. Int. J. Pharm. Sci. Nanotechnol. 2022;15:6043\u20136054."}, {"Citation": "Sim W.K., Park J.H., Kim K.Y., Chung I.S. Robustaflavone induces G0/G1 cell cycle arrest and apoptosis in human umbilical vein endothelial cells and exhibits anti-angiogenic effects in vivo. Sci. Rep. 2020;10:1\u201312. doi: 10.1038/s41598-020-67993-5.", "ArticleIdList": ["10.1038/s41598-020-67993-5", "PMC7338547", "32632123"]}]}], "History": [{"Year": "2023", "Month": "5", "Day": "25"}, {"Year": "2024", "Month": "2", "Day": "2"}, {"Year": "2024", "Month": "2", "Day": "2"}, {"Year": "2024", "Month": "2", "Day": "21", "Hour": "11", "Minute": "16"}, {"Year": "2024", "Month": "2", "Day": "21", "Hour": "11", "Minute": "15"}, {"Year": "2024", "Month": "2", "Day": "21", "Hour": "4", "Minute": "3"}, {"Year": "2024", "Month": "2", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["38379969", "PMC10877303", "10.1016/j.heliyon.2024.e25837", "S2405-8440(24)01868-1"]}}]}